About AIM
AIM is a Healthcare company based in Voorburg (Netherlands) founded in 2009, and was acquired by Blue Matter Consulting in January 2021. AIM is focused on supply chain solutions for life sciences. It operates on a Professional Services model. AIM offers products and services including Supply Chain Development, Consulting, Maintenance Support, and Interim Professionals. Its focus areas include Life Sciences and Supply Chain Solutions.
Company details
AIM is dedicated to providing specialized supply chain consultancy and interim professional solutions for life science companies, including pharmaceutical, biotech, and medical device sectors. Services are offered across strategy, design, implementation, and maintenance support. Clients are served throughout Europe and North America, with expertise in biotech products, vaccines, and diagnostics. Comprehensive support is provided to start-ups and established companies for successful market launches.
- Headquarters Voorburg, Netherlands
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website aimconnection.eu
- Social LinkedIn
- Acquired by Blue Matter Consulting (Jan 2021)
- Investors
- Acquired byBlue Matter Consulting
(Jan 2021)
Products & Services of AIM
AIM offers a comprehensive portfolio of products and services, including Supply Chain Development, Consulting, Maintenance Support, and Interim Professionals.
Supply chain strategy is designed for life science startups.
Strategic consulting is provided for supply chain challenges.
Ongoing management is offered for supply chain functions.
Experienced professionals are provided for temporary critical roles.
Investors in AIM
AIM has secured backing from 1 investor. Prominent investors backing the company include Blue Matter Consulting.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of consulting services focused for clinical drug development | 2012 | bluematterconsulting.com | San Francisco, United States |
Investor details for AIM
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of AIM
2 dated milestones of AIM across 12 years, from founding to its latest funding, stage changes and deals.
- Founded AIM is founded.
- Exit Acquired by Blue Matter Consulting.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AIM
AIM was founded in 2009.
AIM is headquartered in Voorburg, Netherlands. It is registered at Voorburg, South Holland, Netherlands.
AIM is dedicated to providing specialized supply chain consultancy and interim professional solutions for life science companies, including pharmaceutical, biotech, and medical device sectors. Services are offered across strategy, design, implementation, and maintenance support. Clients are served throughout Europe and North America, with expertise in biotech products, vaccines, and diagnostics. Comprehensive support is provided to start-ups and established companies for successful market launches.
AIM offers Supply Chain Development, Consulting, Maintenance Support, and Interim Professionals.
AIM has 1 investor. Key investors include Blue Matter Consulting.
Yes. AIM was acquired by Blue Matter Consulting in January 2021.